[ad_1] <br><a target="_blank" href="https://www.benzinga.com/general/biotech/21/12/24815133/lexaria-receives-independent-review-board-approval-for-dehydratech-cbd-human-clinical-study-hyper" rel="noopener">Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4; Dosing Expected To Begin By Apr. 2022</a> <font color="#6f6f6f">Benzinga</font> <br>[ad_2] <br><a href="https://www.benzinga.com/general/biotech/21/12/24815133/lexaria-receives-independent-review-board-approval-for-dehydratech-cbd-human-clinical-study-hyper">Source link </a>